FGD5 and central nervous system cancer: Collectively, our findings illuminate the intricate regulatory mechanism governing LAPTM4A, underscoring the significance of the FGD5-AS1-hsa-miR-103a-3p-LAPTM4A axis in the regulation of glioma progression.